CCN2 and breast cancer: TAZ was firstly identified as a novel gene responsible for paclitaxel resistance in breast cancer via interacting with TEADs and transcriptionally activating connective tissue growth factor (CTGF) and cysteine-rich 61 (Cyr61) [80].